First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma
First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma
Not yet recruiting · NCT06097455 · Registry updated 2023-10-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Early phase 1 | 2023-10-26 | NCT06097455 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fundacion Clinic per a la Recerca Biomédica | 30 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Santiago de Compostela | Santiago de Compostela | Spain | 1 |
| H. Clínico de Salamanca | Salamanca | Spain | 1 |
| H. Ramon y Cajal | Madrid | Spain | 1 |
| H.U. Virgen de la Arrixaca | Murcia | Spain | 1 |
| Hospital Central de Asturias | Oviedo | Spain | 4 |
| Hospital Clínic Barcelona | Barcelona | Spain | 5 |
| Hospital Son Espases | Palma de Mallorca | Spain | 6 |